IASO Bio presents first-in-human data of BCMA-targeted in vivo CAR-T cell therapy IASO206 at 2026 IMS

Innovent expands global Phase 3 study of IBI363/TAK-928 to include non-squamous NSCLC

Akeso enrols first patient in global Phase III trial of cadonilimab vs nivolumab in first-line gastric cancer

Lundbeck to relocate US headquarters to Greater Boston

FDA approves WELIREG and LENVIMA combination for previously treated advanced renal cell carcinoma

AstraZeneca's IMFINZI combination receives US Priority Review for muscle-invasive bladder cancer

Novotech to acquire Agilex Biolabs from Healius

ACROBiosystems launches CHO-Direct and ACRO AIx to accelerate AI-driven drug discovery

UChicago Medicine completes construction phase of new cancer facility

REGENXBIO reports positive three-year durability data for surabgene lomparvovec in diabetic retinopathy

Viking Therapeutics plans offerings of common stock and convertible senior notes

Astellas doses first patient in Phase 3 lung cancer study

AstraZeneca's Trixeo Aerosphere approved in EU for asthma maintenance treatment

Ondine Biomedical deployssteriwave across five Southern Ontario hospitals

Ionis reports positive Phase 3 sefaxersen data in IgA nephropathy